Novartis Animal Health UK Ltd has announced the launch of CLiKZiN Pour On for sheep, a short meat withhold period (MWP) product that can be used throughout Spring and Summer for the prevention of blowfly strike in sheep and lambs.
CLiKZiN is a ready-to-use water-based product that protects sheep for eight weeks, and has a meat withhold period of seven days. The product is a line extension of CLiK which offers a longer period of protection at 16 weeks and has a longer withhold period of 40 days. Novartis says that used in conjunction with CLiK, CLiKZiN offers versatile protection throughout the year.
The launch of CLiKZiN comes at the same time that Vetrazin has been reformulated, resulting in a longer meat withhold period for sheep treated with the product.
Thomas Tiley MRCVS from Novartis Animal Health said: "Farmers need reliable protection from the repugnant threat of blowfly strike. CLiKZiN provides eight weeks blowfly prevention together with the trusted performance and safety record associated with CLiK. It also offers the greater flexibility of a seven day meat withhold.
"This makes CLiKZiN ideally suited for a variety of production schedules and stock including lambs for slaughter and pre-shearing ewes."
Blowfly strike can be devastating to sheep, causing severe impact on the welfare of the animal. Within days of a blowfly laying its eggs, clinically normal sheep can be afflicted with flesh eating maggots. This makes prompt and effective treatment critical.
National Sheep Association Chief Executive Peter Morris said: "Fly strike is a terrible burden to the sheep industry both in terms of the welfare of the sheep and economically.
"Having a product available that gives effective prevention against fly strike whilst at the same time having a withdrawal period which does not impinge on the ability of the sheep farmer to market lambs is very welcome. The sheep farmers' armoury against the every day afflictions which affect sheep has been significantly enhanced."
Petplan is giving away a VIP trip for two people to this year's 'Petplan Veterinary Awards' in Birmingham on 31st March.
The prize includes two admission tickets to the awards ceremony, as well as accommodation at a top hotel in Birmingham.
Veterinary staff can be in with a chance at winning this exclusive opportunity by nominating their practice or a member of staff for the following awards:
Alison Andrew, Petplan's Marketing Manager, said, "Veterinary professionals up and down the country show great commitment and dedication to our pets everyday and the awards are an opportunity to recognise all their hard work. By nominating a colleague you can not only show them your appreciation but you can also going into the draw to win a fantastic night out"
By making a nomination at www.petplan.co.uk/vetawards you'll automatically be entered into the draw to win the VIP tickets to the evening.
Nominations for the awards close on the 4th February and the winner of the VIP tickets will be announced in late February.
Bayer Animal Health has taken over the marketing and sales of the antibiotic Nisamox (tablets containing Amoxicillin and Clavulanic Acid), from Fort Dodge Animal Health.
Under the new arrangement, the design of Nisamox tablet packaging will change to reflect the change of ownership, however, Bayer says the quality of the tablets and the competitive pricing remain unchanged.
Nisamox tablets are licensed for use in cats and dogs to treat infections of the skin, urinary tract, and respiratory tract caused by susceptible Staphylococci, and also to treat enteritis and urinary tract infections caused by susceptible E.coli.
Nisamox tablets will continue to be available in three strengths: 50mg, 250mg, and 500mg. For information on Nisamox tablets, contact your Bayer territory manager.
Brinsea has announced the launch of the new Vetario range of intensive care units.
The company says the new models are the result of a 2 year design programme to provide the ideal environment for the successful recovery of small mammals, reptiles and birds.
The new S40 and S50 models incorporate the features found on the previous S10 and S20 models, but with improvements to the control systems, sturdiness and ease of cleaning.
According to the blurb: "The two models are approximately 40 and 100 litres volume respectively, and available with either standard or 'M' control systems. The cabinets are moulded from tough, gloss-finished ABS, making them durable and easy to clean. The importance of cleaning extends to all aspects of the design: the cabinets split to allow the base to be immersed and the fan and heater are both easily accessed for cleaning. The digital push button control panels are wipe clean without disturbing the settings. The 'M' models show humidity (as well as temperature) and include temperature and power-off alarms, enriched oxygen compatibility and nebuliser fitting. Inlet and recirculating filters keep the risks of respiratory problems from airborne contamination to a minimum. Both models are portable, which makes them ideal for isolating animals: a sensitive cat recovering from an anaesthetic can be safely accommodated away from barking dogs, for example."
Prices start at £420 (including 20% VAT).
For more information, telephone: 0845 226 0120
The RCVS has advised that veterinary surgeons should delegate Schedule 3 work to veterinary nurse students only during students' training, following a series of queries from employers about such students locuming.
Veterinary surgeons have dispensations under Schedule 3 of the Veterinary Surgeons Act to delegate to student veterinary nurses in the course of their training, so that students can learn how to give medical treatments to animals.
Crucially, these dispensations apply only when the student is working as a student in their approved training practice or on a placement organised by their university, and is under the supervision of qualified staff.
These dispensations do not apply to any extra-curricula activity so, if working as locums, they are legally classified as unqualified lay staff
The RCVS is concerned that locum agencies do not always appear to know this and are placing locums in their capacity as students, or even "senior students." This has the potential to mislead employers and the students concerned, and result in illegal practice.
Liz Branscombe, Chairman of the RCVS Veterinary Nurses Council said: "We know that student VNs, especially those on university courses, often undertake locum work to supplement their earnings. However, beyond the training practice which employs them, or in a placement organised by their university, they can only carry out tasks that may be expected of an unqualified staff member, and cannot legally undertake Schedule 3 work."
Practices may check the details of a student VN directly with the RCVS or with the student's college. If you notice an agency promoting student VN locums, please contact the RCVS so that we can provide guidance.
A three and a half year old white German shepherd dog from Dorchester, Dorset, has become the first in the world to have an ankle amputation prosthesis.
Mitzi Davis was trampled by a horse which crushed her foot, tearing off all blood and nerve supply, back in October 2010.
In a pioneering procedure, Dr. Noel Fitzpatrick from Fitzpatrick Referrals fitted a titanium implant to the bone below her joint - the first time a prosthesis has been put in a fully articulating bone of a dog.
The ITAP implant (which stands for Intraosseous Transcutaneous Amputation Prosthesis) is a new way of attaching prosthetic limbs. It involves implanting a titanium rod in the bone, onto which skin can attach just like a deer's antler, leaving a "peg" sticking out of the skin which can't get infected because of the resilient seal. The technology was developed for dogs by Professor Gordon Blunn at University College London (UCL) in association with Dr. Fitzpatrick.
The "exo-prosthesis" or foot is then screwed onto the peg and can be changed and modified as necessary. First Mitzi's gait had to be modelled on a computer, much like in a CGI movie. Then a foot was made using computer finite element analysis, designed so that the material of the foot would absorb shock from the ground and, most importantly, snap and break before the implant in the bone or the bone itself.
Dr. Noel Fitzpatrick said: "Today of course has implications not only for animals but for human amputees in the future and I will continue to work closely with Professor Blunn and the Stanmore Implants team to advance this technology to improve the quality of life for animals and eventually, for humans."
The ITAP technology is being tested in humans and has already been used to create a prosthetic for a woman who lost her arm in the July 2005 London bombings.
Professor Blunn said: "Humans and other animals share a large number of degenerative musculo-skeletal conditions. The repair process of the musculoskeletal system is essentially the same whether in a dog, cat or human being. Reconstruction of the musculoskeletal system share common problems and the interchange of information between both veterinary and human orthopaedics is very important. Therefore treating animals is not only ethical in its own right but is a useful paradigm for human orthopaedics.
"Treating Mitzi with an ITAP device has proved to be beneficial and the information learned from this case has been directly applied to human surgery. Mitzi's ITAP is made from titanium alloy which is attached to the residual bone. The surface of the implant is coated with hydroxyapatite which enhances bone attachment, securing the implant in place. Part of the implant just underlying the skin has a surface which encourages dermal and epidermal attachment. This ties the skin into the implant and produces a seal preventing infection. This implant has been adopted for human use."
Eurovet Animal Health has launched Vomend, a new veterinary licensed metoclopramide that can be used to treat vomiting and reduced gastro-intestinal motility in both dogs and cats.
Eurovet says that for years, vets have often had little choice but to use metoclopramide preparations designed for human use - therefore effectively off-licence. This new preparation will allow vets to use a medication they know is of great benefit in treating dogs and cats, without taking all the additional precautions required for off-licence use, such as having clients sign consent forms.
The product can also be used in puppies and kittens. Severe vomiting in young puppies particularly can quickly lead to dehydration and depression, so it is vital to control the clinical signs and prevent fluid loss. Vomend will, according to the company, be particularly useful in this regard. As well as being an anti-emetic Vomend is also a pro-kinetic upper GI tract stimulant, so it is indicated for use in chronic nephritis, pyloric spasm and drug induced digestive intolerance.
Vomend will be available in 20 ml and 10 ml vials, providing greater flexibility over usage and stock control.
For further information on Vomend contact Eurovet on 01223 257933 or order direct from your wholesaler from early February.
Ed's note: The name. Is it just me? Wouldn't 'Tummyeaze' or something (anything) have been better?
The RCVS Disciplinary Committee has this week directed that the name of a Grimsby veterinary surgeon should be removed from the RCVS Register, having found him guilty of serious professional misconduct for advising and undertaking surgical procedures without sufficient clinical grounds or considering alternative treatment options; failing to obtain the informed consent of his clients; undertaking procedures outside his area of competence; failing to refer or discuss the option of referral to a specialist; and, failing to provide his patients with adequate pain relief.
Mr Joseph Lennox Holmes, of Waltham Veterinary Clinic, Grimsby, faced nine charges relating to two separate complaints, at a two-week hearing in October which resumed this week.
These complaints concerned four consecutive staphylectomies and a tracheostomy that Mr Holmes performed on Jake, a Cavalier King Charles Spaniel owned by Ms Marsden; the dental treatment he gave to three Persian cats called Dream Topping, Charlie Brown and Henry, together with the advice he gave to their owner, Mrs Auckland.
On 25 October 2007, Mr Holmes performed a staphylectomy on Jake during dental surgery. He gave the Committee various reasons why he thought the procedure was necessary; however, the Committee accepted the opinion of two expert witnesses Professor Dan Brockman, a specialist in soft tissue surgery at the Royal Veterinary College, and Mr Andrew Ash, the senior veterinary surgeon at a 17-vet small animal practice, that there were insufficient clinical grounds for such a surgical procedure to be undertaken. The Committee also found Mr Holmes had not adequately considered other treatments, or obtained fully informed consent from Jake's owner for this procedure.
Mr Holmes performed further staphylectomies and a tracheostomy on Jake, a procedure described by Professor Brockman as "by definition, high risk and best performed by a specialist". He did not consider referral, or inform Mrs Marsden that such referral was an option. Nor did he provide sufficient aftercare or pain relief. Following these surgeries, Jake was euthanased .
In the second complaint, Mr Holmes performed dental extractions on two cats, Dream Topping and Henry, and advised removing teeth from a third, Charlie Brown, in October 2008. The Committee, however, accepted the view of expert witness Mr Ash and Dr David Crossley, RCVS Recognised Specialist in Veterinary Dentistry, that the dental extractions performed, and the advice given, were not justified on the available clinical evidence. The Committee also found that Mr Holmes did not discuss alternative treatment options with Mrs Auckland, or obtain her informed consent. In the case of Dream Topping, consent was sought after the cat had been sedated for an unrelated procedure and Mrs Auckland had felt under pressure to consent.
Mr Holmes had also relied on anaesthesia-inducing drugs to provide analgesia for the dental extractions, without any other form of pain relief. The Committee agreed with the expert witnesses that this was wholly inadequate.
The Committee found many aggravating factors in both cases, including actual injury to animals from unnecessary surgery, and a serious breach of the trust in which Mr Holmes' clients had placed in him to make the welfare of their animals his primary consideration. His repeated misconduct had been sustained over a period of time in the face of a previous adverse finding of the Committee in 2006.
It also found that Mr Holmes failed to appreciate when a case was outwith his experience, and had continued his course of action despite Jake's deterioration; he had not considered referral or accepted that others in the profession might know more than he did; in formulating clinical practice and policies, he made no reference to peer-reviewed literature or continued professional development; and, his use of outmoded drugs and medicines intended for human use was of concern, as was his lack of appreciation of the need for adequate pain relief when performing painful surgical procedures.
Towards the end of the hearing, Mr Holmes said in mitigation that he regretted unreservedly any adverse effects that his treatment had had on the animals concerned, and that he now realised that his long history of working alone had allowed him to become professionally isolated, to become over-confident in the value of his own experience and rather "set in his ways".
Having given serious consideration to postponing judgment, subject to undertakings from Mr Holmes, Disciplinary Committee Chairman Mrs Caroline Freedman said: "We are mindful that the sanction which we apply must be proportionate to the nature and extent of the misconduct found proved and must balance the public interests against the interests of the Respondent.
"We are, however, also mindful of Mr Holmes' conduct during the previous 11½ days of the hearing, during which time his every action was vigorously defended and no insight whatsoever was shown."
The Committee also considered suspending Mr Holmes from the Register. "In view of the serious and long-term nature of the conduct found proved in the charges, we do not feel that it is appropriate that Mr Holmes should be permitted to return to the Register without further assessment of his efforts to update his knowledge," said Mrs Freedman, before concluding: "The only appropriate sanction in each case is that the Registrar be directed to remove Mr Holmes' name from the Register."
The British Small Animal Veterinary Association (BSAVA) has announced that it is opening its membership to RCVS registered veterinary nurses for the first time.
BSAVA has always been keenly involved with veterinary nurse issues and has representation on the RCVS nurse Awarding Body Board and observers on VN Council. Membership Development Committee Chair Patricia Colville said: "The association strongly believes that are nurses are integral to the care the profession offers to patients, and we have always taken advice from our members on ways we can support nurses on the many issues that they have been faced with over the last number of years, from the change in nurse training to compulsory CPD and the future change to self-regulation. Now it is time to formally recognise the services we offer to VNs and bring them into a package of benefits that they can collect as a member of the Association".
Patricia added: "There have been many changes over the last 50 years, during which nurse training has developed in its own right. The depth and breadth of knowledge that nurses have, and the amount of work that they have to do to gain the VN qualification is vast and it is a great credit to the veterinary world that this level of dedication has developed. It is fantastic to see the amount of CPD on offer now and the enthusiasm and dedication that nurses show in continuing to develop their skills, which has contributed to the betterment of practice life and animal welfare".
Membership for VNs is being launched at the first year introductory price of £66 in 2011, rising to £100 per annum in 2012.
Practices interested in how BSAVA membership can support their nursing staff, and veterinary nurses interested in membership should register at http://www.bsava.com/, email administration@bsava.com or call 01452 726700.
Equine vets and farriers in South Wales who need horses x-rayed can now use a new mobile service offered by Equiray. Operating 24 hours a day, 7 days a week, Equiray's technicians travel to the site to take digital x-rays, using state-of-the-art imaging equipment.
At the heart of Equiray's service is the Uno Equine portable digital x-ray system; the only system in the world that has a capture screen built into the generator. All images taken can be viewed within minutes and decisions made there and then regarding further tests. The x-ray images are emailed to the veterinary surgeon immediately, or supplied to the practice on a CD or memory stick. They are also stored securely by Equiray for a 3 month period.
For farriers, the image can be displayed on screen so they can see the internal bone structures encapsulated within the hoof before they start remedial work, and then another x-ray taken after the work has been completed. Both images can be viewed together for comparison.
Equiray says its service means practices don't have to buy and maintain costly equipment, nor send a practice technician to attend with the vet, as all Equiray technicians are highly skilled in equine imaging.
Equiray currently operates mainly in South Wales but with requests coming from other areas of the country, the company says its technicians are travelling to x-ray several horses in a particular area, over a 2 day period. Remedial farriers requiring monthly x-rays of certain horses are also using the service and plans to extend the service nationally are in progress.
For more information, visit www.equiray.co.uk/
Merial has highlighted two new studies which the company says demonstrates the efficacy and safety of its canine NSAID, Previcox.
In the first study, Lecoindre and Pepin evaluated the beneficial effects of once daily administration of 5mg/kg Previcox to dogs suffering from osteoarthritis (OA) for 90 days. According to the company, response to treatment was excellent, with significant improvements observed in lameness scores, pain on manipulation of the affected joint and range of motion. Of particular note was the fact that the degree of improvement increased with duration of treatment, clearly demonstrating the benefits of longer term treatment. These results support the findings of a recent review of the safety and efficacy of long-term NSAID use in dogs with OA. The product's safety profile was also evaluated by means of biochemistry and haematology assessments. In addition, regular gastroscopic examinations were used to directly visualise the effect of treatment on the gastric mucosa. These safety assessments demonstrated that Previcox therapy was well tolerated, with no significant treatment related changes seen on biochemistry or gastroscopy, despite the fact that this was a geriatric population which included a number of dogs with a prior history of gastrointestinal tract disease.
Merials says the findings from a different study by Joubert, published in the South African Veterinary Journal, provide further confirmation of the beneficial effects of 90 days Previcox treatment in a geriatric population of dogs.
Commenting on the results of the two studies, Kevin Whelan, Merial's Veterinary Technical Manager said: "The outcome from these studies provide further evidence for the benefits of long term use of Previcox in dogs suffering from osteoarthritis. There is relatively little published information available on the use of NSAIDs in older dogs, and these results confirm that Previcox is well tolerated in this group of patients."
For further information about Previcox, please contact your local Territory Manager or call 0870 6000 123.
References:
BCF Technology has launched the portable 9020HF Orange x-ray generator from Eco Ray.
BCF says the 9020HF is ideal for equine and large animal applications because it is is just marginally heavier than the 8016HF generator, but more powerful, allowing it to achieve excellent images of regions such as the stifle and spine.
The new BCF Clinical Development Manager and in-house vet Kimberly Palgrave said: "This new generator really fills the gap in the range and is an ideal balance between weight and power. It is also bright orange so impossible to miss when tidying the kit away in the yard."
BCF is also the sole official distributor in the UK and Ireland for Eco Ray generators.
To see the full range of X-ray generators and other X-ray and ultrasound equipment available from BCF visit http://www.bcftechnology.com/ or call +44 (0)1506 460023.
Dechra Veterinary Products has launched a new Instruments and Consumables catalogue for veterinary professionals. The new catalogue is available to view online or download via Dechra's website at www.dechra.com
The new catalogue features the range of instruments and consumables available from Dechra, including a new wound dressing Silflex. This dressing is an atraumatic soft silicone contact layer, which minimises trauma at dressing change and protects delicate skin. Other products include Activon Medical Grade Manuka Honey dressings, Portex Jacksons cat catheters, Surgivet Slippery Sam cat catheters, ET tubes and 3M Vetrap bandaging tape.
The Dechra catalogue also includes help and advice for veterinary professionals, including step-by-step instructions for using some products and case studies for the range of wound dressings.
From 2 April - 2 May, National Pet Month will be encouraging people to get happy and healthy spending time with their pets, with its theme of 'Happiness is... time with your pet'.
Organisers say that during the month, thousands of people will be celebrating happy times with their pets at hundreds of events up and down the country. While many of these events will raise funds for local animal charities, National Pet Month is not just about fund raising. It is also all about raising awareness of how pets make people's lives happier and healthier, and how they can repay the pets they love by looking after them responsibly.
Veterinary practices can get involved in National Pet Month, and show what they have to offer clients and potential clients. Details of how to join in and become a supporter are on the website http://www.nationalpetmonth.org.uk/.
Last year's National Pet Month was apparently the most successful to date, with a record number of 1200 events and nearly £80,000 raised for at least 30 animal charities.
The 2010 overall best National Pet Month event was held by St Boniface Vets in Crediton, Devon. They participated by visiting local nursery and primary schools teaching children about pet health, and specifically raising awareness of exotic animals as pets. Phil Sketchley, Chairman of NPM said: "The 14 excellent educational visits that St Boniface made to local schools and nurseries were inspirational. They were a fantastic example of the partnerships that can be forged between practices and the community during National Pet Month."
He added: "School visits are one great way for practices to get involved - but there are many more. Our top veterinary practice 2010 event, for example, was held by Mill House Vets in Kings Lynn, and which focussed on educating owners on caring for older pets. National Pet Month is an opportunity to help your clients learn more about responsible pet care so they can enjoy their pets for many years to come."
In contrast to the British Veterinary Association, The National Office of Animal Health (NOAH) has welcomed the decision by DEFRA not to proceed with the proposal contained in the draft Veterinary Medicines Regulations 2010 to prohibit the advertising of antimicrobials to farmers.
NOAH says it believes the proposal would have had a negative effect on farmers' ability to maintain their knowledge and awareness of animal health and welfare issues, and did not believe that it would reduce antimicrobial resistance profiles.
NOAH chief executive Phil Sketchley said: "Farmers, as professional producers of food, need to be kept well briefed on the antimicrobials they use, following prescription by their veterinary surgeons. Promotion by our members plays a key role in this and in educating farmers about animal welfare and disease."
NOAH members follow rigid rules on advertising and promotion through the longstanding Code of Practice for the Promotion of Animal Medicines.
Phil added: "The NOAH Code already goes beyond the Veterinary Medicines Regulations and is reviewed each year - this year we will be particularly looking to ensure that it fully reflects the industry's commitment to disease education and information on responsible use, particularly in relation to antimicrobial promotion. We have planned, at our Code review meeting in February, further discussions within NOAH and with the VMD to finalise how this can best be achieved.
"Importantly we must always remember that antimicrobial medicines for all animals are POM-V, meaning they have to be prescribed by a veterinary surgeon, and therefore it should be the vet who makes the decision on whether an antibiotic is needed. If such therapy is indicated, the most appropriate antibiotic for an animal or group of animals is selected by the veterinary surgeon based on the clinical signs shown, the current disease situation on the farm and in the area and where appropriate and feasible, is based on bacterial culture and sensitivity testing."
Using promotion to encourage responsible use, NOAH launched its 'Use Medicines Responsibly' campaign in 2009. A recommendation was made that members include a strap line on promotional material advising users to 'use medicines responsibly'.
NOAH was a founder member of the Responsible Use of Medicines in Agriculture Alliance (RUMA) and continues to be a strong contributor to and supporter of RUMA's communications to farmers including the antimicrobial guidelines. These guidelines are not intended to influence the veterinary surgeon's decision to prescribe but help support ways that the veterinary surgeon and farmer can work together to reduce the need to prescribe antimicrobials whilst ensuring they are used responsibly once prescribed in line with the principle of 'as little as possible but as much as necessary'.
Phil said: "Antibiotics are essential for the health and welfare of the UK's livestock population. NOAH accepts that antimicrobial resistance is a serious and growing subject of discussion for the medical and veterinary professions and we need to continue to take this matter seriously."
Veterinary surgeons Lewis Grant and Professor Quintin McKellar have joined Dr Lydia Brown in the New Year's Honours List.
Mr Grant, former veterinary manager in the Meat Hygiene Service, Food Standards Agency and animal welfare representative of the Veterinary Public Health Association (VPHA) was awarded an MBE. Professor Quintin McKellar, Principal of the Royal Veterinary College has been awarded a CBE for services to science.
BVA Honorary Member the Earl of Selborne was also recognised with a GBE for services to science.
Harvey Locke, President of the BVA, said: "On behalf of the BVA I would like to congratulate Dr Brown, Lewis Grant, Professor McKellar and Lord Selborne on their fantastic achievements. These national honours underline the importance of veterinary medicine."
Vets attending the first veterinary-led European Equine Transport Forum, held in Brussels last November, have agreed that the profession needs to take a leading role to help enforce the current regulation governing the long-distance transport of horses, in order for equine welfare standards to be improved.
In support, the British Equine Veterinary Association (BEVA) Trust has announced the introduction of the BEVA Trust Equine Transport Enforcement Award of €1000, to be given annually to the individual or group doing the most to improve enforcement of the current transport regulation.
The Forum was initiated by BEVA President Madeleine Campbell in conjunction with the Federation of Veterinarians of Europe (FVE) and is sponsored by the BEVA Trust and World Horse Welfare. It attracted representatives from 38 nations; including a strong turnout from Eastern Europe where horses sourced for slaughter often start their journeys and Italy which is the end destination for the majority of these horses.
The plight of horses sourced for slaughter was the main focus for discussion and the key issues raised were:
Delegates also examined the long-term need to change the attitude of Italian consumers, raising awareness of the current welfare issues related to their preference for fresh meat, labelled as Italian produce. In addition they discussed the impact on equine welfare of increased profits in sourcing horses in Eastern Europe and then transporting them long distances for slaughter.
Dr Madeleine Campbell said: "The atmosphere throughout the day was one of collaboration and determination to succeed. Proper enforcement of the current regulation is the key to welfare improvements, as is the need for a system of best practice to drive a change in cultural attitudes about how horse meat is produced. A process of education is necessary so that consumers understand the welfare issues associated with long-distance transport and start demanding accurate information about where the meat which they are buying originally came from, and how far the horses travelled to slaughter. We are all in agreement that vets have a pivotal role to play in both education and enforcement, and that they want to play it."
Nominations for the annual BEVA Trust Equine Transport Enforcement Award are open and can be made via the FVE and the BEVA Trust. The award will be judged by the FVE Working Group on Transport, and will be awarded for the first time in November 2011. The programme, abstracts and presentations from the Forum can be found at: http://www.fve.org/events/index.html#conferences
The President of the Veterinary Benevolent Fund (VBF) Dr Lydia Brown has been awarded an MBE in the Queen's New Years Honours List, for services to the veterinary profession.
Lydia qualified as a veterinary surgeon from Liverpool and has spent most of her professional career in commerce. She was a member of Council of the Royal College of Veterinary Surgeons from 1991- 2007 and President in 1998-1999. During this period, she mobilised the veterinary profession to support the establishment of the Veterinary Surgeons Health Support Programme (VSHSP), which was launched in 1999 to help vets recover from addictive diseases and mental health problems. Since then the programme has helped some 300 vets and supported their families and colleagues in practice.
From 1993-1998 Lydia was a member of the Steering Committee of VetHelpline, a 24/7 telephone line for vets and their families, vet students and vet nurses who wish to discuss emotional, addictive or financial problems empathetically with someone who has experience of the profession. She became a Director of the VBF in 2005, when the Fund merged with VSHSP and VetHelpline under the umbrella of the VBF, and was elected President of the Fund in 2006.
Lydia said: "It gives me great pleasure to receive this award. The achievements of the VBF reflect the tireless work of many colleagues, who give their time unstintingly to help members of the profession less fortunate than themselves."
Harvey Locke, President of the British Veterinary Association, said: "This is a fitting award in recognition of Dr Brown's tremendous achievements. She is an eminent member of the veterinary profession who works tirelessly and compassionately to help others.
"The high prevalence of depression and suicide in the veterinary profession is well documented and Dr Brown has been instrumental in ensuring that help and support is available to help veterinary surgeons, veterinary students and veterinary nurses in need."
Lydia is active in a number of areas of the veterinary profession and is also a lay canon and member of chapter of Salisbury Cathedral, and a non-executive Director of the Salisbury NHS Foundation Trust Hospital.
The British Veterinary Association has welcomed the tightening up of sales of veterinary medicines on the internet but has expressed disappointment that the advertising of antimicrobials to farmers will continue.
The Veterinary Medicines Directorate has today published its response to the public consultation on the Veterinary Medicines Regulations, which are updated every year.
The new Regulations, which come into force in April 2011, introduce new controls on internet pharmacies meaning that only approved websites will be legally allowed to dispense and supply veterinary medicines. The controls will come into force in April 2012 and the BVA supports the use of a logo on approved websites to help consumers buy medicines from reputable sources.
The BVA has previously expressed concern that pet owners could inadvertently buy counterfeit veterinary medicines online and urges veterinary clients to seek advice from their vet and only buy from UK-based companies.
Harvey Locke, President of the BVA, said: "Without proper regulation online pharmacies could be sourcing drugs from overseas and selling counterfeit medicines that look genuine to unsuspecting pet owners. These medicines are placebos at best and dangerous at worst.
"We therefore welcome the VMD's decision to clampdown on irresponsible online retailers and provide a clear logo for approved websites that will give pet owners confidence.
"We have also asked the VMD to put a stop to the increasing problem of prescription fraud and we hope the tighter regulation announced today will be a step towards achieving that aim.
"However, we would urge all pet owners to continue talking to their vet about sourcing medicines from the internet to make sure the right drugs are bought and administered correctly."
In light of increasing concerns about the growth of antimicrobial resistance the VMD's consultation canvassed views on restricting the advertising of antimicrobials to farmers. The BVA says it supported a ban on advertising as a sensible approach to the responsible use of antimicrobials, and is disappointed that the VMD has decided not to go ahead with it. Mr Locke said: "New antimicrobials are heavily advertised by pharmaceutical companies to vets and farmers so it is vital that the message of responsible use is not lost.
"Antimicrobial resistance is a serious issue for both animal and human health and we are disappointed that the VMD is not restricting the advertising of these products to farmers. The pharmaceutical companies must now undertake to advertise responsibly.
"Ultimately, it is the veterinary surgeon who will make the decision on which veterinary products to use and vets and farmers should work together to ensure antimicrobials are used prudently and responsibly."
Hill's Pet Nutrition is offering a series of free webinars about feline medicine, delivered by some of the best-known experts in the field.
The first presentation on feline liver disease will be delivered by Danièlle Gunn-Moore BVM&S BSc PhD MACVSc MRCVS, on the 26th January 2011. Martha Cannon BA VetMB DSAM(fel) MRCVS (pictured right) will present the next two webinars on Renal disease on 2nd March and Chronic Diarrhoea on 4th May. Both speakers are RCVS Specialists in feline medicine. Norman Johnston BVM&S, Dipl. AVDC, Dipl. EVDC, MRCVS, will be discussing stomatitis in the cat - a particularly problematic disease - on the 18th May. Norman is an RCVS, American and European Specialist in Veterinary Dentistry. The series will end on 8th June with Duncan Lascelles BSc, BVSc, PhD, CertVA, DSAS (ST), DECVS, DACVS, Associate Professor in Small Animal Surgery at North Carolina State, talking about osteoarthritis in the cat.
The events kick off at 8.30 pm and are hosted by the Webinar Vet (www.thewebinarvet.com). One initial registration provides access to the complete series, with scheduled e-mail reminders sent out prior to the latest webinar. To register, go to www.thewebinarvet.com/hills and enter your details as well as the code hillsnl.
Webinars are ideal for time pressed individuals who may not always be able to travel to a distant venue, yet still offer a 'real- time' and interactive experience. No special equipment is required, other than a reasonable standard PC or MAC and a broadband connection. The events are open to both vets and nurses but early registration is advisable to take full advantage of the whole Hill's Feline webinar series.
Hill's Pet Nutrition is offering veterinary surgeons, vet students and nurses in the UK an opportunity to look round its Pet Nutrition Centre in Topeka, Kansas, via a live webcast to be delivered at 7pm on Tuesday 11th January 2011.
To join the webcast, which will last around 1.5 hours, go to http://www.fc-tv.com/webcast/keystone/hills/jan-11-11 and enter the password pnctour. This event is specifically for veterinary surgeons, veterinary students and veterinary nurses only.
Tim Dobbins, Associate Veterinary Affairs Manager said: "We look forward to our colleagues joining us for this special live webcast and hearing some of the latest thinking that explains the science behind some of our most exciting products."
Novartis Animal Health has issued the following statement concerning the supply of acepromazine (ACP) injectable in the UK:
"Recent upgrades to Novartis Animal Health’s manufacturing plant in the UK have resulted in the site becoming a worldwide centre of excellence for the production of bulk liquids. This upgrade has had an impact on the manufacture of ACP 2mg/ml and 10mg/ml injectable products, which will no longer be produced in the UK.
From January 2011, Novartis Animal Health will no longer be able to supply ACP Injection 2mg/ml or ACP Injection 10mg/ml to wholesalers. However, it is not Novartis’ intention to discontinue the supply of acepromazine injectable; in order to ensure consistency of supply to the UK market the company will be importing the Vetoquinol French product Calmivet.
Calmivet is a monovalent acepromazine injection licensed for use in dogs, cats and horses, available as a 5mg/ml injection, 50ml vial.
In order to obtain Calmivet from wholesalers, veterinarians will need to apply for a free of charge Special Import Certificate from the VMD. This can be completed on line at www.vmd.gov.uk.
It is anticipated that this situation will continue for at least the first 6 months of 2011, until an alternative manufacturing site is established. As soon as we have more information on the timelines this will be communicated.
A full communication including a prep room reminder poster and Calmivet product leaflet has been mailed to all UK practices.
Vetoquinol UK are not responsible for the distribution or technical support of this product, so any queries should be directed to Novartis Animal Health UK on 01276 694402.
The production and supply of ACP Tablets 10mg remains unaffected."
Intervet/Schering-Plough Animal Health has launched its complimentary blood testing service that allows practitioners to investigate one of the main infectious causes of early embryo loss in sheep flocks.
The annual subsidised Barren EweCheck diagnostic scheme is available from 1st December 2010 until 31st March 2011 for breeding ewe flocks. The service establishes whether Toxoplasma gondii is potentially implicated in any empty or aborting ewes.
According to the company, data from the Barren EweCheck and FlockCheck 2010 schemes showed that 86% of flocks had been exposed to the toxoplasma parasite at some point before blood sampling. As a result, practitioners were able to give clients receiving a positive diagnosis timely advice on disease control and the benefits of a Toxovax vaccination regime.
The company anticipates full availability of Toxovax in 2011 and says its Barren EweCheck blood sample submission pads are available directly from the company's Veterinary Support Group by calling 01908 685685.
Alternative remedies which could be dangerous to pets are being targeted by the Government in a major drive to improve animal health and welfare. Some herbal and homeopathic products are claiming medicinal benefits without scientific proof, meaning they may not properly treat or prevent serious diseases, leaving pets at risk.
The Veterinary Medicines Directorate’s (VMD) Director of Operations, John FitzGerald, said: "Some of these products are claiming to be effective and safe when no scientific evidence has been presented to us to show they are.
"Animal owners have a right to know if a product does what it claims. The products claim to treat diseases which can cause serious welfare problems and in some circumstances kill animals if not properly treated. So in some cases owners are giving remedies to their pets which don’t treat the problem."
A number of unauthorised products are being targeted, including:
From now on, the VMD will be contacting manufacturers to ensure that they demonstrate the products are safe and provide the benefits which they claim to. If this is not the case the manufacturers will be required to re-brand the products to make it clear they are not medicinal.
Supporting the action, British Veterinary Association President Harvey Locke said: "As veterinary surgeons we rely on the use of safe, effective and quality medicines for the health and welfare of animals under our care – and there must always be sound scientific evidence to back up medicinal claims made by the manufacturer of any product.
"Some of these unauthorised products may at the least be ineffective and at worst could cause harm because serious life-threatening diseases may go undiagnosed. We would urge animal owners always to check with their veterinary surgeon before giving any remedy or supplement to their pet."
With dysentery apparently at its highest level for many years, Pfizer Animal Health has launched a new campaign to help increase awareness of the benefits of selecting the best prevention and treatment options.
Nigel Lodge MRCVS, Pfizer technical manager said: "The increase in dysentery can be attributed to a combination of factors including more frequent movement of weaners and a reduction in the level of feed medication resulting from the increasing use of more vaccines against other disease.
"With the early onset of winter, we know that dysentery will survive outside the pig for up to seven weeks in cold moist conditions and other pathogens for considerably longer."
The campaign is headed by a new guide, 'Enteric Disease Management', which looks at prevention and treatment of the problem, one of the most costly to the producer. Dysentery alone is estimated to cost more than £10 / pig finished considering higher mortality, increased feed costs and non-marketable animals.
The guide says that according to the housing system some of the pathogens have extremely long survival times - three months for E coli, nine months for salmonella and one year for coronavirus (transmissible gastroenteritis). It provides advice on limiting infection and reducing stress on the pigs.
Mr Lodge says that the incidence of dysentery fluctuates in different areas of the country with varying antibiotic sensitivity. Hence, a sensitivity test is essential when deciding on a particular medication.
With enteric diseases in general, there are a wide range of causes - including bacteria, viruses, parasites, management or nutrition. Mr Lodge said: "The causal agent can sometimes be diagnosed from clinical signs, such as dysentery, but generally post mortem and laboratory diagnosis is required.
"There are various antibiotic products which can be used but all should only be used after management issues such as bio security, pen management and rodent control have been addressed.
"Some products are specific in their activity, such as Lincocin Premix and swine dysentery. Others have a broad spectrum of activity and should be used where mixed infections are diagnosed. Linco-Spectin Premix, for instance, is active against E coli, Salmonella, ileitis, swine dysentery and other enteric bacteria."
Copies of the new publication - including a competition to win two prizes of one tonne of pig feed - are available from Pfizer Animal Health via Scott Wheway Tel: 01737 330941 or scott.a.wheway@pfizer.com